USP7 and acute myeloid leukemia: Cartel et al. (2021) demonstrated that USP7 inhibition significantly reduces cell proliferation in vitro and in vivo, blocks the progression of DNA replication, and increases cell death in Acute Myeloid Leukemia (AML) [38].